MSLT-I-response of clinical trial investigators
- PMID: 25311346
- DOI: 10.1038/nrclinonc.2014.65-c2
MSLT-I-response of clinical trial investigators
Comment on
-
Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention.Nat Rev Clin Oncol. 2014 May;11(5):248-9. doi: 10.1038/nrclinonc.2014.64. Epub 2014 Apr 8. Nat Rev Clin Oncol. 2014. PMID: 24710577 No abstract available.
-
Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma?Nat Rev Clin Oncol. 2014 May;11(5):245-6. doi: 10.1038/nrclinonc.2014.65. Epub 2014 Apr 15. Nat Rev Clin Oncol. 2014. PMID: 24732941 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
